ライフサイエンスコーパス: abnormal finding

1 pendix (>7 mm in diameter) was considered an abnormal finding.

2 Quantitative sensory testing showed abnormal findings.

3 low-up is necessary in cases with borderline abnormal findings.

4 prior neurologic involvement was related to abnormal findings.

5 Three patients had no abnormal findings.

6 mount images that contained both normal and abnormal findings.

7 g parenchyma cavities were the most frequent abnormal findings.

8 n and spine at an outside hospital showed no abnormal findings.

9 graphs, with about 50% of radiographs having abnormal findings.

10 tional tests were reserved for athletes with abnormal findings.

11 4% for the subset of cases with no pertinent abnormal findings.

12 year of a screening pelvic examination with abnormal findings.

13 ry test and complete blood count revealed no abnormal findings.

14 stratified indications based on the yield of abnormal findings.

15 d brain CT (not shown) showed the absence of abnormal findings.

16 Ninety-six percent of the scans had abnormal findings.

17 Only 1 of 69 positive FCL did not accompany abnormal findings.

18 pecific pathologic parameters for women with abnormal findings.

19 chest radiography performed, 12 (70.6%) had abnormal findings.

20 ere more likely to have thoracic images with abnormal findings (10 of 14 patients [71%; 95% CI: 47, 9

21 Of the 18% demonstrating incidental abnormal findings, 15.1% required no referral; 1.8%, rou

22 , type, and clinical urgency (category 1, no abnormal findings; 2, no referral recommended; 3, consid

23 re described and categorized (category 1, no abnormal findings; 2, no referral recommended; 3; consid

24 Equal numbers of children with abnormal findings (29 of 45, 64%) and normal findings (5

25 Pathologic murmur had the highest yield of abnormal findings (40%).

26 QR, 3-17) from symptom onset, 75 (77.3%) had abnormal findings: 74 (76.3%) had late gadolinium enhanc

27 Age was a significant predictor of an abnormal finding after adjusting for indication and site

28 ent malapposition has been reported to be an abnormal finding after vascular brachytherapy and, possi

29 for evaluating the aggressiveness of PCa for abnormal findings allocated in different prostate zones.

30 In MS, DTI abnormal findings along tracts correlated with quantitat

31 These abnormal findings also appear in many pediatric eyes wit

32 c health record repository for patients with abnormal findings and lack of associated follow-up actio

33 to communicate important, but not emergent, abnormal findings and recommended follow-up to two commu

34 Patients with abnormal findings are referred to the ophthalmology serv

35 Patients with possible abnormal findings are scheduled for a face-to-face exami

36 0-8) by assigning the following weights for abnormal findings: arterio-alveolar gradient, 3 points;

37 of 20 participants (15%, 95% CI 3%-38%) had abnormal findings associated with their TMVL.

38 Thirty-two of 41 participants (78%) with abnormal findings at 3-month follow-up CT underwent repe

39 Background Abnormal findings at brain MRI in patients with neurolog

40 by using available technology in women with abnormal findings at conventional breast imaging who und

41 performed in 13 patients with hematuria and abnormal findings at conventional cystoscopy.

42 represented false-positive findings, with no abnormal findings at endoscopy.

43 -six of 27 patients with clinical stroke had abnormal findings at imaging, but even if patients with

44 ut clinical stroke), and 49% (78 of 158) had abnormal findings at MR angiography.

45 h uncommon VA morphology had higher rates of abnormal findings at multimodality assessment and more f

46 y, specificity, positive predictive value of abnormal findings at screening (PPV(1)), positive predic

47 nd positive predictive values (PPVs) (PPV of abnormal findings at screening [PPV1], PPV of biopsies r

48 Ten (8.0%) patients were judged to have abnormal findings by using the duplex Doppler US and STO

49 ant on both PET and conventional imaging for abnormal findings compatible with metastatic disease.

50 The criteria for abnormal findings compatible with the diagnosis of APN w

51 1030 (86%) of 1192 subjects had at least one abnormal finding described in the whole-body CT screenin

52 Decisions regarding therapy directed towards abnormal findings detected during screening should be ma

53 s, 34.0% (95% CI, 24.7%-43.3%) had 1 or more abnormal findings during the vision screening, and 8% (9

54 hare codes for diseases, signs and symptoms, abnormal findings, etc.

55 out disease, the high specificity of certain abnormal findings greatly increases the probability of b

56 or early infarction (group B, n = 35), or no abnormal findings (group C, n = 13).

57 metabolic monitoring, and quick response to abnormal findings has resulted in remarkably low recipie

58 Abnormal findings identified with MRI and CT were compar

59 Odds of an abnormal finding in an A or M TTE were 6 times that of R

60 owed benign findings in 95 (64.6%) women and abnormal findings in 11 (7.5%) women; one or both ovarie

61 Initial MRI scans showed abnormal findings in 15 of 38 (39.5%) patients, mostly w

62 ment was accessed in 76 instances (75%) with abnormal findings in 23.

63 isease within the surrounding mesentery, and abnormal findings in adjacent structures.

64 Abnormal findings in individual patients, suggestive of

65 definite for DSD on CT (grades 3-4), 11 had abnormal findings in the cervical spine, 16 in the thora

66 itial MRI of the brain at admission revealed abnormal findings in the left supratentorial brain (Figs

67 itial MRI of the brain at admission revealed abnormal findings in the left supratentorial brain.

68 Of the 150 patients, 63 (42.0%) had no abnormal findings in the spine on PET (grade 0), 27 (18.

69 however, was not spatially specific because abnormal findings in WM tracts also related to cortical

70 These abnormal findings included an FVC < 80% of predicted in

71 The abnormal findings included focal lesions in the basal ga

72 ed motor assessments that indicate congruent abnormal findings indicative of cerebral palsy.

73 Because not every abnormal finding may require treatment, the terms abnorm

74 of an ANN with radiologists' descriptions of abnormal findings may improve interpretation of mammogra

75 Peribronchial thickening was the most common abnormal finding, observed in 57% of patients.

76 Although an abnormal finding on (18)F-FDG PET/CT was added to the 20

77 t recommendation for chest CT to evaluate an abnormal finding on an outpatient chest radiographic exa

78 es at base line that were associated with an abnormal finding on CT of the head were an age of at lea

79 elders with ocular disorders (defined as any abnormal finding on eye examination) was determined.

80 Catheters are the second most common abnormal finding on radiographs.

81 evere and extensive CAD had neither of these abnormal findings on adenosine MPS.

82 Eight of 10 cancer survivors had abnormal findings on brain, heart, and bone images, incl

83 Abnormal findings on cardiac MRI were frequent.

84 Both patients had abnormal findings on chest radiographs.

85 Abnormal findings on CMR (hazard ratio, 2.77 [95% CI, 1.

86 d to identify those who are unlikely to have abnormal findings on CT of the head.

87 The prevalence of abnormal findings on cytopathological examination of vag

88 cts who underwent prostate biopsy because of abnormal findings on digital rectal examination or eleva

89 d prostate-specific antigen concentration or abnormal findings on digital rectal examination underwen

90 While being studied, patients with abnormal findings on dilated ophthalmoscopy and OCT comp

91 The associations of abnormal findings on early and late CUS with neurobehavi

92 servational study, the clinical relevance of abnormal findings on early brain imaging after MTBI is d

93 servational study, the clinical relevance of abnormal findings on early brain imaging after MTBI is d

94 Specific abnormal findings on electronic monitoring of the fetal

95 LCO or FVC on the second set of PFTs and had abnormal findings on followup BAL fluid analysis.

96 ts presenting with TMVL, 15% of patients had abnormal findings on further investigations.

97 independent clinical predictors of important abnormal findings on head CT were identified: age (adjus

98 and hybrid imaging, diagnostically relevant abnormal findings on higher-quality CT studies have been

99 he incidence of neoplasia in persons with no abnormal findings on initial examination are limited.

100 ported gastrointestinal side effects and had abnormal findings on LFTs.

101 establish the frequency and significance of abnormal findings on low-amperage-CT cardiac SPECT/CT sc

102 t treatment (in the radioiodine group only), abnormal findings on neck ultrasonography, or elevated l

103 rubinemia (17 percent) had "questionable" or abnormal findings on neurologic examination, as compared

104 foetal alcohol spectrum disorder have shown abnormal findings on OCT.

105 Abnormal findings on optical coherence tomography (OCT)

106 luation; 60 percent (15 of 25) of those with abnormal findings on physical examination that were cons

107 ommended only if the patient has symptoms or abnormal findings on physical examination.

108 y 4 of 30 patients (13%) with metastasis had abnormal findings on simultaneous liver function tests.

109 Prevalence of abnormal findings on systemic testing.

110 The most common abnormal findings on the chest CT scan were pulmonary no

111 cal correlates and diagnostic specificity of abnormal findings on the neurological examination in fir

112 ndings provide neurobiological validation of abnormal findings on the neurological examination.

113 Potentially significant abnormal findings on the nondiagnostic-CT portion of the

114 Electronic medical records were reviewed for abnormal findings on ultra-widefield fluorescein angiogr

115 Abnormal findings on ultrasonography warrant further eva

116 on initial or follow-up examination but had abnormal findings on UWFFA or OCT.

117 tion control personnel for identification of abnormal findings prior to distribution.

118 Positive findings included abnormal findings related to malignant lesions (suspecte

119 region, and small bronchi and bronchioles), abnormal findings (reticulation, tiny nodules, altered a

120 All abnormal findings revealed by these neuroimaging techniq

121 ions leading to critical illness and with no abnormal findings scored in Confusion Assessment Method

122 at VLST in DES and BMS had a wide variety of abnormal findings, such as neoatherosclerosis, uncovered

123 le aspiration, suspected enlarging mass, and abnormal findings suggesting metastasis on a diagnostic

124 Abnormal findings suggestive of SARS-CoV-2 cardiac invol

125 ical adaptations in athletes from distinctly abnormal findings suggestive of underlying pathology.

126 fy prospectively marked benign-appearing and abnormal findings that were seen on only one standard pr

127 ases were identified as those with normal or abnormal findings, the latter being a case that required

128 Of 10,673 patients with abnormal findings, the trigger flagged 1,256 patients (1

129 e rectified, such as failure to follow-up on abnormal findings; these significantly increased the ris

130 litatively analyzed for training-related and abnormal findings using the International Recommendation

131 None had abnormal findings visible during endoscopy.

132 The most common abnormal finding was ischemic lesions in small vessels (

133 The most common abnormal finding was small vessel disease (20%).

134 er per number of screening examinations with abnormal findings was 3% (three of 88) for mammography a

135 At least 1 of the 3 abnormal findings was identified by pulmonary tests in 3

136 Abnormal findings were appendicitis (n=13), urinary trac

137 Abnormal findings were cholelithiasis (n=3), obstructive

138 Abnormal findings were corroborated by a fellowship-trai

139 Among those with any workup, abnormal findings were detected in 21 of 33 (63.6%).

140 Abnormal findings were found in 134 patients (78.8%) dur

141 Abnormal findings were identified by consensus of standa

142 Abnormal findings were more common in patients <1 year o

143 Abnormal findings were noted in 36.8% of patients and th

144 Abnormal findings were observed in 5 of 72 patients (7%)

145 nt video capsule endoscopy (VCE) and typical abnormal findings were observed in all patients.

146 The most common abnormal findings were papilledema in 86 of 164 patients

147 The detected abnormal findings were recorded as being in the region a

148 Patients with abnormal findings were reexamined at intervals ranging f

149 Overall, Cirrus significantly displayed abnormal findings while both Stratus and Spectralis disp

150 is OCT showed a significantly higher rate of abnormal findings while Cirrus displayed normal results

151 Colposcopy showed no abnormal findings with either tampon and no changes in v